ABAI Adopts New Board Eligibility Policy
In April 2013, the ABAI Board of Directors approved a new Board Eligibility policy with the following requirements:
Trainees must achieve ABAI Board certification within five years after successfully completing an ACGME-approved fellowship training program in Allergy and Immunology, which typically takes two-to three-years. For those who completed training prior to 2012, eligibility to sit for the certification examination will expire in 2017. If the trainee does not accomplish this certification, they will lose their status as "Board-Eligible" and they will be required to successfully complete, in its entirety, a re-entry pathway consisting of the following:
- An ABAI Communication Module
- An ABAI Patient Safety Module
- The Allergy and Immunology In-Training Examination
- Evidence of 50 Allergy/Immunology-specific CME credits per year
Note: Participation in an AAAAI/ACAAI-sponsored Allergy and Immunology Board review course is strongly recommended.
Once Board eligibility has been re-established, the candidate has three years to successfully pass the ABAI Certification Examination.
